Mariano, F.; Mella, A.; Randone, P.; Agostini, F.; Bergamo, D.; Berardino, M.; Biancone, L.
Safety and Metabolic Tolerance of Citrate Anticoagulation in Critically Ill Polytrauma Patients with Acute Kidney Injury Requiring an Early Continuous Kidney Replacement Therapy. Biomedicines 2023, 11, 2570.
https://doi.org/10.3390/biomedicines11092570
AMA Style
Mariano F, Mella A, Randone P, Agostini F, Bergamo D, Berardino M, Biancone L.
Safety and Metabolic Tolerance of Citrate Anticoagulation in Critically Ill Polytrauma Patients with Acute Kidney Injury Requiring an Early Continuous Kidney Replacement Therapy. Biomedicines. 2023; 11(9):2570.
https://doi.org/10.3390/biomedicines11092570
Chicago/Turabian Style
Mariano, Filippo, Alberto Mella, Paolo Randone, Fulvio Agostini, Daniela Bergamo, Maurizio Berardino, and Luigi Biancone.
2023. "Safety and Metabolic Tolerance of Citrate Anticoagulation in Critically Ill Polytrauma Patients with Acute Kidney Injury Requiring an Early Continuous Kidney Replacement Therapy" Biomedicines 11, no. 9: 2570.
https://doi.org/10.3390/biomedicines11092570
APA Style
Mariano, F., Mella, A., Randone, P., Agostini, F., Bergamo, D., Berardino, M., & Biancone, L.
(2023). Safety and Metabolic Tolerance of Citrate Anticoagulation in Critically Ill Polytrauma Patients with Acute Kidney Injury Requiring an Early Continuous Kidney Replacement Therapy. Biomedicines, 11(9), 2570.
https://doi.org/10.3390/biomedicines11092570
